RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial

TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial

Add to Collection
RCTs CF Burant, P Viswanathan, J Marcinak, C Cao… - The Lancet, 2012 - Elsevier

Chapter : Section2
Journal Year : 2012
Cited by : 257

… period was undertaken in which patients were randomly assigned to receive TAK-875 (6·25, 25, 50, 100, or 200 mg), glimepiride (4 mg), or placebo followed by a 2-week follow-up …..... Read More

Keywords : ['phase randomise doubleblind placebocontrolle trial', 'type diabetes mellitus', 'versus placebo', 'glimepiride']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0140673611618795
Google Scholar Link : https://scholar.google.com/scholar?cites=8735105612365431374&as_sdt=2005&sciodt=0,5&hl=en&num=20